Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Shield Thera (STX)

Price 2.00p on 28-03-2024 at 08:50:00
Change 0.00p 0%
Buy 2.05p
Sell 1.95p
Buy / Sell STX Shares
Last Trade: Buy 50,000.00 at 2.035p
Day's Volume: 63,051
Last Close: 2.00p
Open: 2.00p
ISIN: GB00BYV81293
Day's Range 2.00p - 2.00p
52wk Range: 1.92p - 12.75p
Market Capitalisation: £16m
VWAP: 2.03563p
Shares in Issue: 782m

Recent Trades History Shield Thera (STX)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 50,000 2.035p Ordinary
08:42:33 - 28-Mar-24
Buy* 12,757 2.038p Ordinary
08:29:08 - 28-Mar-24
Buy* 294 2.0399p Ordinary
08:00:08 - 28-Mar-24

Share Price History for Shield Thera

Time period:
to
Date Open High Low Close Volume

Share News for Shield Thera

LONDON MARKET CLOSE: FTSE 100 takes hit ahead of FOMC minutes

21st Feb 2024 16:57

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors anxiously look ahead to this evening's Federal Open Market Committee meeting minutes. Read More

Shield Therapeutics sinks as strong performance marred by data issues

21st Feb 2024 12:36

(Alliance News) - Shield Therapeutics PLC on Wednesday said that it was expecting stellar results for 2023, but this success was overshadowed by a mistake in the company's previous prescription forecasts. Read More

IN BRIEF: Shield Therapeutics hires former Akili leader as new CFO

9th Jan 2024 11:33

Shield Therapeutics PLC - Commercial-stage pharmaceutical company focused on iron deficiency product Accrufer - Hires Santosh Shanbhag as chief financial officer, effective next Tuesday. He replaces Hans-Peter Rudolf, who left Shield in October to pursue new opportunities. Shanbhag was previously CFO of Nasdaq-listed Akili Inc, which he "helped transform...from a private to a public entity". Before this, he held various senior finance leadership roles at Vertex Pharmaceuticals Inc, including as Head of International Finance & Accounting. Read More

TRADING UPDATES: Comptoir opens restaurant; Intercede wins contract

7th Dec 2023 15:31

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

IN BRIEF: Shield Therapeutics Chief Financial Officer Rudolf to leave

12th Oct 2023 11:14

Shield Therapeutics PLC - commercial-stage pharmaceutical company focusing on its iron deficiency product Accrufer - Chief Financial Officer Hans-Peter Rudolf will leave the company next week Friday to pursue other opportunities. The firm's company controller, Paul Spoors, will take on the CFO role on an interim basis. Shield says it has engaged an executive search firm to identify a new CFO. Read More

FTSE 100 Latest
Value7,956.53
Change24.55

Login to your account

Forgot Password?

Not Registered